ArticleFrontiers in oncology2022

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer.

Brendan Knapp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.